<p>(A) unimmunized macaques, (B) SHIV-immunized macaques and (C) progesterone-treated, SHIV-immunized macaques. In panel (D), cumulative vRNA levels over the 20 weeks of observation were transformed into areas under the curve (AUC) and the median AUC of the 3 groups of animals were compared. The Kruskal-Wallis test and a pair-wise comparison between the 2 groups of immunized animals and the unimmunized group using Dunn's multiple comparisons test were performed.</p
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
<p>(a) Dose-dependent inhibition of viral replication by IFNα. Each data point represents the averag...
<p>The numbers of the six macaques injected (2 macaques/gp in three different studies) are indicated...
<p>(A) Changes in plasma viral loads after challenge vaccinated macaques possessing MHC-I haplotype ...
<p>Animals were infected at week 0 and were (A) untreated or (B) treated with 3 or 4 antiretroviral ...
(A) Schematic of the study procedures (B-C) The concentrations of VRC01 (B) and Rh-α4β7 (C) were mea...
<p>In the left panels are reported the (<b>A</b>) plasma viremia and (<b>B</b>) the proviral DNA of ...
<p>A) Challenge scheme. Macaques were exposed to SIV on day 0 and subsequently bled on days 7 and 10...
<p>(A) List of naive controls and NAb-immunized macaques. Experiments using macaques indicated by as...
<p>A total of nine female Indian rhesus macaques were divided into treatment groups of five animals ...
<p><i>Mamu-A1*001:01</i> rhesus macaques were vaccinated intravenously with SIVmac239Δnef and intrav...
<p>Plasma viral loads (SIV <i>gag</i> RNA copies/ml plasma) were determined as described previously ...
<p><b>(A)</b> Plasma viral RNA levels and (<b>B)</b> CD4 T cell counts in 7B2 IgG_AAA and palivizuma...
<p><sup>1</sup>Totally 38 infected and 6 uninfected rhesus macaques were used in this study, and vRN...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
<p>(a) Dose-dependent inhibition of viral replication by IFNα. Each data point represents the averag...
<p>The numbers of the six macaques injected (2 macaques/gp in three different studies) are indicated...
<p>(A) Changes in plasma viral loads after challenge vaccinated macaques possessing MHC-I haplotype ...
<p>Animals were infected at week 0 and were (A) untreated or (B) treated with 3 or 4 antiretroviral ...
(A) Schematic of the study procedures (B-C) The concentrations of VRC01 (B) and Rh-α4β7 (C) were mea...
<p>In the left panels are reported the (<b>A</b>) plasma viremia and (<b>B</b>) the proviral DNA of ...
<p>A) Challenge scheme. Macaques were exposed to SIV on day 0 and subsequently bled on days 7 and 10...
<p>(A) List of naive controls and NAb-immunized macaques. Experiments using macaques indicated by as...
<p>A total of nine female Indian rhesus macaques were divided into treatment groups of five animals ...
<p><i>Mamu-A1*001:01</i> rhesus macaques were vaccinated intravenously with SIVmac239Δnef and intrav...
<p>Plasma viral loads (SIV <i>gag</i> RNA copies/ml plasma) were determined as described previously ...
<p><b>(A)</b> Plasma viral RNA levels and (<b>B)</b> CD4 T cell counts in 7B2 IgG_AAA and palivizuma...
<p><sup>1</sup>Totally 38 infected and 6 uninfected rhesus macaques were used in this study, and vRN...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
VRC01 protects macaques from vaginal SHIV infection after a single high-dose challenge. Infusion of ...
<p>(a) Dose-dependent inhibition of viral replication by IFNα. Each data point represents the averag...